Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 4/15/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Zvi Ram?

Zvi Ram

Neurosurgeon, Head of Neurosurgery Department

The Tel Aviv Sourasky Medical Center

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

The Tel Aviv Sourasky Medical Center

Find other employees at this company (206)

Background Information

Employment History

Chairman Department of Neurosurgery

TAM


Chairman, Department of Neurosurgery

Tel Aviv Medical Center , Tel-Aviv


Affiliations

Brain Tumor Biotech Center

Medical Advisory Board Member


ImmunoCellular Therapeutics, Ltd.

Scientific Advisory Board Member


AANS/CNS

Member of the Executive Committee of the Section


Education

M.D.


Web References(23 Total References)


Israeli doctors | MedPlus Ltd

medplus-israel.com [cached]

Prof. Zvi Ram
Prof. Zvi Ram Neurosurgeon, head of Neurosurgery Department at The Tel Aviv Sourasky Medical Center . Graduated Sackler School of Medicine, today Dr. Ram is present professor of surgery (neurosurgery), that has an extensive practical experience recognized by several awards.


Novocure Announces Agenda for Research and Development Day on Dec. 12, 2016 | Business Wire

www.businesswire.com [cached]

Zvi Ram, MD, Director of Neurosurgery at the Tel-Aviv Sourasky Medical Center in Tel-Aviv
1:25 to 1:50 p.m.: TTFields and GBM, and the full, 695-patient dataset from Novocure's EF-14 trial in newly diagnosed GBM, Dr. Ram


www.eurekalert.org

Professor Zvi Ram presents phase III recurrent glioblastoma survival and quality of life data from the first pivotal study of the NovoTTF-100A at 15th Annual Society for Neuro-Oncology Scientific Meeting
Professor Zvi Ram presents phase III recurrent glioblastoma survival and quality of life data from the first pivotal study of the NovoTTF-100A at 15th Annual Society for Neuro-Oncology Scientific Meeting Professor Zvi Ram presents phase III recurrent glioblastoma survival and quality of life data from the first pivotal study of the NovoTTF-100A at 15th Annual Society for Neuro-Oncology Scientific Meeting MONTREAL, CANADA - November 19, 2010 - Data presented today from a pivotal, phase III randomized clinical trial for patients with recurrent glioblastoma tumors suggest that Tumor Treating Fields (TTF) therapy may increase median survival time and improve quality of life scores compared to best standard of care chemotherapy. Professor Zvi Ram, chairman of the Department of Neurosurgery at Tel-Aviv Sourasky Medical Center, presented the data at the Society for Neuro-Oncology (SNO) Annual Scientific Meeting. "The study suggests that patients treated with TTF therapy, as defined in the protocol, lived significantly longer than patients treated with the currently available best chemotherapeutic regimens," said Professor Ram.


www.eurekalert.org

Professor Zvi Ram presents phase III recurrent glioblastoma survival and quality of life data from the first pivotal study of the NovoTTF-100A at 15th Annual Society for Neuro-Oncology Scientific Meeting
Data presented today from a pivotal, phase III randomized clinical trial for patients with recurrent glioblastoma tumors suggest that tumor treating fields therapy may increase median survival time and improve quality of life scores compared to best standard of care chemotherapy. Professor Zvi Ram, chairman of the Department of Neurosurgery at Tel-Aviv Sourasky Medical Center, presented the data at the Society for Neuro-Oncology Annual Scientific Meeting.


www.braintumorbiotechsummit.org

Zvi Ram, MD.  Tel Aviv


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory